At the intersection of DNA Replication and Genome integrity: Functional characterisation of the replicative helicase MCM2-7 during S-phase and replication stress.
At the intersection of DNA Replication and Genome integrity: Functional characterisation of the replicative helicase MCM2-7 during S-phase and replication stress.
批准号:
505087959
负责人:
Dr. Luitpold Maximilian Reuter
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
DNA复制是所有生物体的基本过程,当DNA复制被错误调控时,就会出现基因组不稳定和癌症的主要原因。迷你染色体维持2-7 (MCM2-7)复合体是一种环状异六聚解旋酶,它在细胞周期的g1期被装载到DNA上,并在细胞进行DNA复制之前保持非活性。然后,MCM2-7被激活,转化为CMG复合物(Cdc45-MCM2-7-GINS),并从其核心挤出一条DNA链。因此,它在复制叉的尖端解开双链DNA (dsDNA)。在这个过程中,MCM2-7提供单链DNA (ssDNA)作为DNA依赖的DNA聚合酶的模板。MCM2-7如何被装载到dsDNA上并在复制起点被激活已经被广泛研究,核心DNA复制过程已经用纯化的蛋白质重建。然而,令人惊讶的是,当遇到诸如自然障碍、DNA损伤或转录-复制冲突等障碍时,对于允许复制机制保持基因组稳定性的分子机制知之甚少。障碍的例子是一般转录因子和转录RNA聚合酶,它们是体积庞大的dna结合蛋白复合物。此外,拓扑应力,如r环,可以导致染色质不稳定。最后,DNA损伤对解旋酶提出了巨大的挑战,特别是单链断裂或链间交联。在所有这些情况下,CMG复合体必须克服DNA损伤,但绕过或暂停机制只是知之甚少。因此,本研究计划的主要目的是揭示受调控的MCM2-7环打开如何促进细胞遗传补体的忠实复制的机制。利用最先进的技术,全基因组分析和化学生物学方法来控制细胞中MCM2-7环的开放,我将解决以下目标:2.在DNA损伤和缺失的情况下,DNA合成过程中MCM2-7环开口要求的阐明描述ssDNA和Mcm10(一种晚期复制激活蛋白)在转录-复制冲突中的作用。将高分辨率测序技术与蛋白质组学相结合,可以精确定义天然DNA结合蛋白复合物,并在DNA复制过程中MCM2-7环打开的背景下对其进行表征。这里提出的工作产生的结果将确定重塑解旋酶,改变染色质景观或去除RNA转录物以避免与癌症直接相关的复制应激的因素,因为DNA复制缺陷和复制应激促进基因组不稳定。此外,MCM2-7的失调与许多恶性肿瘤有关。综上所述,本研究旨在从MCM2-7环打开的新角度系统分析DNA复制和转录事件的交叉点,以保障基因组的完整性。
英文摘要
DNA Replication is an essential process in all living organisms, and when misregulated presents a major cause of genomic instability and cancer. The Mini Chromosome Maintenance 2-7 (MCM2-7) complex is a ring-shaped heterohexameric helicase, which is loaded onto DNA in G1-phase of the cell cycle and remains inactive until the cell commits to DNA replication. Then, MCM2-7 is activated, transformed into the CMG complex (Cdc45-MCM2-7-GINS) and extrudes a single DNA strand from its core. Consequently , it unwinds double-stranded DNA (dsDNA) at the tip of the replication fork. During this process, MCM2-7 provides single-stranded DNA (ssDNA) as a template for the DNA-dependent DNA polymerases. How MCM2-7 is loaded onto dsDNA and activated at replication origins has been widely studied, and the core DNA replication process has been reconstituted with purified proteins. However, surprisingly little is known about the molecular mechanisms that allow the replication machinery to preserve genomic stability when encountering obstacles such as natural roadblocks, DNA damage, or transcription-replication conflicts. Examples for roadblocks are general transcription factors and transcribing RNA polymerases, which are bulky, DNA-bound protein complexes. Furthermore, topological stresses, such as R-loops, can cause chromatin destabilisation. Finally, DNA damage presents a huge challenge for the unwinding helicase, particularly single strand breaks or interstrand crosslinks. In all these cases the CMG complex must overcome a DNA insult but bypassing or pausing mechanisms are only poorly understood. Therefore, the main objective of this research proposal is to uncover the mechanisms how regulated MCM2-7 ring opening contributes to faithful duplication of the genetic complement of the cell. Using state-of the-art techniques, genome-wide analyses, and a chemical-biology approach to control MCM2-7 ring opening in cells, I will tackle the following aims: 1.) Elucidation of MCM2-7 ring opening requirements during DNA synthesis in the absence and presence of DNA damage and 2.) Characterising the roles of ssDNA and Mcm10, a late replication activation protein, in transcription-replication conflicts.Combining high resolution sequencing techniques with proteomics will allow the precise definition of native DNA-bound protein complexes and their characterisation in context of MCM2-7 ring opening during DNA replication. The results generated by the work proposed here will identify factors that remodel the helicase, alter the chromatin landscape, or remove RNA transcripts to avoid replication stress with a direct relevance to cancer, as defects in DNA replication and replications stress promote genomic instability. Furthermore, MCM2-7 misregulation has been linked to many malignancies. In summary, this proposal aims to systematically analyse the intersection of DNA replication and transcription events that safeguard genome integrity with a new angle on MCM2-7 ring opening.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional analysis of the MCM2-7 DNA entry/exit gate during S-phase
-
批准号:336963304
-
项目类别:Research Fellowships
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Dr. Luitpold Maximilian Reuter
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PCV2茎环结构DNA激活cGAS-STING通路诱导的天然免疫应答的作用研究
-
批准号:2026JJ50413
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王东亮
-
依托单位:
机械力响应型DNA探针用于肿瘤微环境细胞力学可视化与药物筛选研究
-
批准号:2026JJ60135
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨思慧
-
依托单位:
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
-
批准号:JCZRLH202601177
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
-
批准号:2026JJ80500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳帆
-
依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
-
批准号:2026JJ81975
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖娇
-
依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究
-
批准号:2026JJ82371
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王哲享
-
依托单位:
CDC45通过调控DNA复制应激促进肝癌发生发展的机制
-
批准号:2026JJ82714
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵志坚
-
依托单位:
基于孕妇外周血游离DNA靶向捕获测序筛查胎儿隐性单基因病的探索研究
-
批准号:JCZRLH202600067
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
WSTF/SNF2H 介导的 DNA 损伤在 DPSCs 衰老中的机制研究
-
批准号:ZCLQN26H1401
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:虞其豪
-
依托单位:
孕期多环芳烃暴露与DNA甲基化改变对子代神经发育影响的出生队列研究
-
批准号:2026JJ81844
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吕玲双
-
依托单位: